At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Aug 12, 2026 at 16:27 ET
Two C-suite insiders at Corcept Therapeutics sold shares on August 10, 2026, totaling $662K in open-market sales. The sales follow derivative exercises and coincide with a period of strong stock performance (market cap $12.4B), but the dollar amount is trivial relative to company size (~0.005% of market cap), making this a routine liquidity event rather than a bearish signal.
- Chief Development Officer Guyer sold 16,300 shares total ($1.85M gross), with 4,770 shares at $114.04 and 11,530 shares at $113.18, all following derivative exercises
- See Remarks officer Maduck sold 1,031 shares at $114.52 ($118K) after exercising derivatives at $8.27
- Total open-market sales: $662K, representing ~0.005% of Corcept's $12.4B market cap
- Both sales occurred on the same day (Aug 10) after derivative exercises, consistent with tax-covering or routine diversification
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access